Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Mycronic AB (publ)    MYCR   SE0000375115

MYCRONIC AB (PUBL)

(MYCR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Mycronic publ : receives order for a Prexision 800 Evo

03/04/2020 | 02:01am EST

Mycronic AB (publ) has received an order for a Prexision 800 Evo mask writer for display applications for deployment in Asia. The order is valued between USD 35 and 40 million. Delivery of the Prexision 800 Evo is scheduled for the first quarter of 2021.

Mycronic offers mask writers for the manufacture of photomasks within different areas of application. These are display manufacturing (TV, smartphones and tablets) and applications within multi-purpose, a broad segment comprising many different application areas. In addition, Mycronic recently launched SLX, a new laser mask writer for the semiconductor industry.

A fully equipped Prexision 800 Evo can, while maintaining productivity, produce patterns that are almost 25 percent more compact than previously possible. This ensures efficient production of the most advanced and critical photomasks for AMOLED displays for smartphones and tablets.

"Receiving the fourth order for a Prexision 800 Evo is a confirmation that Mycronic's most advanced mask writer is firmly established in the photomask industry, supporting the latest technology trends in the display market", says Charlott Samuelsson, Sr VP Pattern Generators at Mycronic.

For additional information, please contact:
Charlott Samuelsson
Sr VP Business Area Pattern Generators
Tel: +46 709 844 282
charlott.samuelsson@mycronic.com

Tobias Bülow
Director Investor Relations
Tel: +46 734 018 216
tobias.bulow@mycronic.com

The information in this press release was published on March 4, 2020 at 8:00 a.m.

About Mycronic
Mycronic AB is a high-tech company engaged in the development, manufacture and marketing of production equipment with high precision and flexibility requirements for the electronics industry. Mycronic headquarters are located in Täby, north of Stockholm and the Group has subsidiaries in China, France, Germany, Japan, the Netherlands, Singapore, South Korea, United Kingdom and the United States. Mycronic is listed on NASDAQ Stockholm. www.mycronic.com

https://news.cision.com/mycronic-ab/r/mycronic-receives-order-for-a-prexision-800-evo,c3051453

https://mb.cision.com/Main/10432/3051453/1204957.pdf

(c) 2020 Cision. All rights reserved., source Press Releases - English

All news about MYCRONIC AB (PUBL)
2020MYCRONIC : receives order for SLX system
AQ
2020MYCRONIC : receives order for two SLX mask writers
AQ
2020MYCRONIC : announces strategic partnership with Cogiscan to provide machine conn..
AQ
2020MYCRONIC : receives order for a SLX and a Prexision Lite 8 Evo mask writer
AQ
2020MYCRONIC : Interim Report January-September 2020
AQ
2020MYCRONIC : appoints Nomination Committee
AQ
2020MYCRONIC AB (PUBL) : Ex-dividend day for final dividend
FA
2020MYCRONIC PUBL : Communiqué from the AGM and statutory Board meeting of Mycronic ..
AQ
2020MYCRONIC PUBL : Welcome to the Annual General meeting in Mycronic AB (publ)
AQ
2020MYCRONIC AB (PUBL) : Ex-dividend day for final dividend
FA
More news
Financials
Sales 2020 3 937 M 469 M 469 M
Net income 2020 692 M 82,5 M 82,5 M
Net cash 2020 937 M 112 M 112 M
P/E ratio 2020 35,1x
Yield 2020 1,14%
Capitalization 24 229 M 2 913 M 2 889 M
EV / Sales 2020 5,92x
EV / Sales 2021 5,18x
Nbr of Employees 1 505
Free-Float 72,2%
Chart MYCRONIC AB (PUBL)
Duration : Period :
Mycronic AB (publ) Technical Analysis Chart | MYCR | SE0000375115 | MarketScreener
Technical analysis trends MYCRONIC AB (PUBL)
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 201,00 SEK
Last Close Price 247,80 SEK
Spread / Highest target -9,20%
Spread / Average Target -18,9%
Spread / Lowest Target -32,2%
EPS Revisions
Managers and Directors
NameTitle
Per Anders Lindqvist President & Chief Executive Officer
Patrik Tigerschiöld Chairman
Lena Båvegård Senior Vice President-Operations
August Torbjörn Gunnar Wingardh Chief Financial Officer
Johan Franzén Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
MYCRONIC AB (PUBL)0.98%2 913
ASML HOLDING N.V.12.53%223 144
LAM RESEARCH CORPORATION18.11%80 327
TOKYO ELECTRON LIMITED10.03%63 357
QORVO, INC.8.30%20 979
ASE TECHNOLOGY HOLDING CO., LTD.21.77%15 073